Facilities

CDC designates new Kentucky biodefense center

Published in Medical Letter on the CDC and FDA, November 24th, 2002

A new biodefense center in Kentucky has been designated by the U.S. Centers for Disease Control and Prevention as one of seven specialty sites in the nation for public health preparedness.

The Center for the Deterrence of Biowarfare and Bioterrorism at the University of Louisville is "unique in its resources and capabilities to research and prepare for a terror-related biological disaster," said Jerry Hauer, U.S. Department of Health and Human Services Assistant Secretary for Public Health Emergency Preparedness.

Faculty at the center have a wide range of expertise, from identifying and developing vaccines to training emergency workers how to respond...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-11-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry